title: [Clinical and experimental validation of the use of the tranquilizer mebikar as a corrective of the neuroleptic syndrome].
abstract: The results of the experimental and clinical studies showed that administration of mebikar in combination with neuroleptics reduced the degree of side effects of the neuroleptics without decreasing their antipsychotic effect.
authors: I E
authors: IE
authors: Zimakova
authors: D G
authors: DG
authors: Semenikhin
authors: A M
authors: AM
authors: Karpov
authors: S V
authors: SV
authors: Kirshin
mesh_terms: D000818:Animals; D001736:Biureas / Q000009:adverse effects / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use; D003214:Conditioning, Classical / Q000187:drug effects; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D004924:Escape Reaction / Q000187:drug effects; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D051381:Rats
chemical_list: D001736:Biureas; C015979:mebikar; D006220:Haloperidol; D002746:Chlorpromazine
vernacular_title: Kliniko-éksperimental'noe obonosvanie primeneniia trankvilizatora mebikara v kachestve korrektora neĭrolepticheskogo sindroma.